773Accesses
Abstract
The aim of this investigation was to prepare microemulsions containing sumatriptan (ST) and sumatriptan succinate (SS) to accomplish rapid delivery of drug to the brain in acute attacks of migraine and perform comparative in vivo evaluation in rats. Sumatriptan microemulsions (SME)/sumatriptan succinate microemulsions (SSME) were prepared using titration method and characterized for drug content, globule size and size distribution, and zeta potential. Biodistribution of SME, SSME, sumatriptan solution (SSS), and marketed product (SMP) in the brain and blood of Swiss albino rats following intranasal and intravenous (IV) administrations were examined using optimized technetium-labeled (99mTc-labeled) ST formulations. The pharmacokinetic parameters, drug targeting efficiency (DTE), and direct drug transport (DTP) were derived. Gamma scintigraphy imaging of rat brain following IV and intranasal administrations were performed to ascertain the localization of drug. SME and SSME were transparent and stable with mean globule size 38±20 nm and zeta potential between −35 to −55 mV. Brain/blood uptake ratios at 0.5 hour following IV administration of SME and intranasal administrations of SME, SMME, and SSS were found to be 0.20, 0.50, 0.60, and 0.26, respectively, suggesting effective transport of drug following intranasal administration of microemulsions. Higher DTE and DTP for mucoadhesive microemulsions indicated more effective targeting following intranasal administration and best brain targeting of ST from mucoadhesive microemulsions. Rat brain scintigraphy endorsed higher uptake of ST into the brain. Studies conclusively demonstrated rapid and larger extent of transport of microemulsion of ST compared with microemulsion of SS, SMP, and SSS into the rat brain. Hence, intranasal delivery of ST microemulsion developed in this investigation can play a promising role in the treatment of acute attacks of migraine.
This is a preview of subscription content,log in via an institution to check access.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
Price includes VAT (Japan)
Instant access to the full article PDF.
Similar content being viewed by others
References
Humphrey PP, Feniuk W, Marriott AS, Tanner RJ, Jackson MR, Tucker ML. Preclinical studies on the anti-migraine drug, sumatriptan.Eur Neurol. 1991;31:282–290.
Pakalnis A, Kring D, Paolicchi J. Parenteral satisfaction with sumatriptan nasal spray in childhood migraine.J Child Neurol. 2003; 18:772–775.
Villalon CM, Centurion D, Valdivia LF, de Vries P, Saxena PR. Migraine: pathophysiology, pharmacology, treatment and future trends.Curr Vasc Pharmacol. 2003;1:71–84.
Ahonen K, Hamalainen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial.Neurology. 2004;62:883–887.
Fuseau E, Petricoul O, Moore KH, Barrow A, Ibbotson T. Clinical pharmacokinetics of intranasal sumatriptan.Clin Pharmacokinet. 2002;41:801–811.
Martindale PK.The Complete Drug Reference. London, UK: Pharmaceutical Press; 1999:450–452.
Gladstone JP, Gawel M. Newer formulations of the triptans: advances in migraine treatment.Drugs. 2003;63:2285–2305.
Chien YW. Nasal Drug Delivery and Delivery Systems. In: Chien YW, Su KSE, Chang S, eds.Nasal Systemic Drug Delivery. New York, NY: Marcel Dekker Inc; 1989:239.
Bigal ME, Bordini CA, Antoniazzi AL, Speciali JG. The triptan formulations: a critical evaluation.Arq Neuropsiquiatr. 2003;61:313–320.
Dahlof C. Clinical applications of new therapeutic deliveries in migraine.Neurology. 2003;61:S31-S34.
Illum L. Nasal drug delivery: problems, possibilities and solutions.J Control Release. 2003;87:187–198.
Illum L. Transport of drugs from the nasal cavity to central nervous system.Eur J Pharm Sci. 2000;11:1–18.
Logemann CD, Rankin LM. Newer Intranasal Migraine Medications.Am Fam Physician [serial online]. 2000. Available at: http://www.aafp.org/afp/20000101/180.html. Accessed: June 15, 2004.
Behl CR, Pimplaskar HK, Sileno AP, De Meireles J, Romeo VD. Effects of physicochemical properties and other factors on systemic nasal delivery.Adv Drug Deliv Rev. 1998;29:89–116.
Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems.Adv Drug Deliv Rev. 2000;45:89–121.
Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery.J Pharm Pharmacol. 2001;53:3–21.
Sinswat P, Tengamnuay P. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl and dimethyl-beta-cyclodextrins.Int J Pharm. 2003;257:15–22.
United States Pharmacopoeial Convention.,United States Pharmacopeia. Asian edition,USP 27. Rockville, MD: United States Pharmacopoeial Convention; 2003.
Roland I, Piel G, Delattre L, Evrard B. Systemic characterization of oil-in-water emulsions for formulation design.Int J Pharm. 2003; 263:85–94.
Jha SK, Dougall P, Behari M, Ahuja GK. Interictal brain 99mTc-HMPAO SPECT study in chronic epilepsy.J Assoc Physicians India. 1998;46:438–441.
Eckelman WC. Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systems.Eur J Nucl Med. 1995;22:249–263.
Saha GB.Physics and Radiobiology of Nuclear Medicine. New York, NY: Springer-Verlag; 1993.
Babbar AK, Singh AK, Goel HC, Chauhan UPS, Sharma RK. Evaluation of 99mTc-labeled Photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy.Nucl Med Biol. 2000;27:419–426.
Koziara JM, Lockman PR, Allen DD, Mumper RJ. In situ blood-brain barrier transport of nanoparticles.Pharm Res. 2003; 20:1772–1778.
Zhang Q, Jiang X, Jiang W, Lu W, Su L, Shi Z. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation of the targeting efficiency to brain.Int J Pharm. 2004;275:85–96.
Chow HS, Chen Z, Matsuura GT. Direct transport of cocaine from the nasal cavity to brain following intranasal cocaine administration in rats.J Pharm Sci. 1999;88:754–758.
Ueda T, Torihara Y, Tsuneyoshi N, Ikeda Y. Effect of sumatriptan on cerebral blood flow during migraine headache: measurement by sequential SPECT used 99mTc-ECD background substraction method.No To Shinkei. 2001;53:625–630.
Stein DJ, Van Heerden B, Wessels CJ, Van Kradenburg J, Warwick J, Wasserman HJ. Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor.Prog Neuropsychopharmacol Biol Psychiatry. 1999;23:1079–1099.
Espinosa-Jimenez M, Padilla-Weigand R, Ontiverous-Ortega A, Ramos-Tejada M, Perea-Carpio R. Interpretation of colloidal dyeing of polyester fabrics pretreated with ethyl xanthogenate in terms of zeta potential and surface free energy balance.J Colloid Interface Sci. 2003;265:227–233.
Block LH. Pharmaceutical Emulsions and Microemulsions. In: Lieberman HA, Rieger MM, Banker GS, eds.Pharmaceutical Dosage Forms. 2nd ed. 2001;47–110.
Nash RA. Pharmaceutical Suspensions. In: Lieberman HA, Rieger MM, Banker GS, eds.Pharmaceutical Dosage Forms. 2nd ed. 2001;1–47.
Fuseau E, Petricoul O, Moore KH, Barrow A, Ibbotson T. Clinical pharmacokinetics of intranasal sumatriptan.Clin Pharmacokinet. 2002;41:801–811.
Li L, Nandi I, Kim KH. Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam.Int J Pharm. 2002;237:77–85.
Vyas TK, Shahiwala A, Marathe S, Misra A. Intranasal drug delivery for brain targeting.Curr Drug Deliv. 2005;2:165–175.
Sakane T, Yamashita S, Yata N, Sezaki H. Transnasal delivery of 5-fluorouracil to the brain in the rat.J Drug Target. 1999; 7:233–240.
Author information
Authors and Affiliations
Pharmacy Department, Faculty of Technology and Engineering, The Maharaja Sayajirao University of Baroda, Kalabhavan, Kalabhavan, Post Box No. 51, 390 001, Vadodara, Gujarat, India
Tushar K. Vyas & Ambikanandan Misra (Professor and Head)
Government of India, Ministry of Defense, Institute of Nuclear Medicine and Allied Sciences, Brig S. K. Mazumdar Marg, Timarpur, 110054, Delhi, India
A. K. Babbar & R. K. Sharma
Center for Cellular and Molecular Biology (CCMB), Uppal Road, 500 007, Hyderabad, A. P., India
Shashi Singh
- Tushar K. Vyas
You can also search for this author inPubMed Google Scholar
- A. K. Babbar
You can also search for this author inPubMed Google Scholar
- R. K. Sharma
You can also search for this author inPubMed Google Scholar
- Shashi Singh
You can also search for this author inPubMed Google Scholar
- Ambikanandan Misra
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toAmbikanandan Misra.
Additional information
Published: January 20, 2006
Rights and permissions
About this article
Cite this article
Vyas, T.K., Babbar, A.K., Sharma, R.K.et al. Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.AAPS PharmSciTech7, 8 (2006). https://doi.org/10.1208/pt070108
Received:
Accepted:
Published: